| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-12 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0004 |